Biocon shares rise 2% after USFDA approval for osteoporosis and bone loss drugs
The Economic Timesarrow_outwardBiocon Biologics secures USFDA approval for Bosaya and Aukelso biosimilars to treat osteoporosis and bone...
Moneycontrolarrow_outwardBiocon Biologics wins USFDA nod for Bosaya and Aukelso, Denosumab Biosimilars
Medical Dialoguesarrow_outwardStock Market LIVE: Nifty, Sensex Fall As ICICI Bank, HDFC Bank Weigh; Adani Group Stocks Advance - NDTV Profit
NDTV Profitarrow_outwardFrom Adani Group, Yes Bank, Biocon to Vedanta- Here are 8 stocks to watch - financialexpress.com
Financialexpress.comarrow_outwardTaking Stock: Market extend gains on 3rd day; Sensex jumps 320 pts, Nifty above 25,400 - TradingView
TradingViewarrow_outwardBiocon Rises 2% as US FDA Approves Denosumab Biosimilars - HDFC Sky
HDFC Skyarrow_outwardBiocon share price rises 3% as arm gets USFDA nod for two drugs; details - Business Standard
Business Standardarrow_outwardStocks in Focus: Biocon, Cochin Shipyard, Yes Bank, and Others - Equitypandit
Equitypanditarrow_outwardStocks to Watch: Bandhan Bank, Cochin Shipyard, Lodha Developers, Biocon & more - CNBC TV18
CNBC TV18arrow_outwardBiocon Share Price: Pharma stock gets rating upgrade from Jefferies; check new target - MSN
MSNarrow_outwardBiocon Limited Just Missed Earnings - But Analysts Have Updated Their Models - simplywall.st
Simplywall.starrow_outwardBiocon Share Price Nears 52-Week High After USFDA Approves Key Diabetes Drug Kristy - Samco
Samcoarrow_outwardBiocon share price surges nearly 2% after FDA nod for insulin injection - Value Research
Value Researcharrow_outwardAfter a $3.3 bn acquisition, is it finally time to look at Biocon? - The Indian Express
The Indian Expressarrow_outwardBiocon shares in focus after board opens up QIP fundraising on 16 June, sets floor price at ₹340.20/share - Mint
Mintarrow_outwardStock to buy today: Biocon (₹354.30) – BUY - BusinessLine
BusinessLinearrow_outwardBiocon's Stock Rebounds Amidst Broader Market Optimism and Small-Cap Gains - Markets Mojo
Markets Mojoarrow_outwardBiocon Q4FY25 Revenue at Rs 4,454 Cr, Up 15%** EBITDA at Rs 1,115 Cr; Up 16%; Net Profit at Rs 344 Cr, Up 153% - Biocon
Bioconarrow_outwardBiocon Share Price Today Down 6% - Equitymaster
Equitymasterarrow_outwardExplained: Why Biocon share price jumped over 7% today - India Today
India Todayarrow_outward
Biocon Share Price close
- 2025-09-19 12:00 event
- 21 sourceslanguage
- 200+ ads_click
- 3 weeks ago schedule